---
title: "AIA Singapore targets 90% of illness claims"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287132135.md"
description: "AIA Singapore has launched a new critical illness plan, AIA Protect 3, targeting cancer, heart attack, and stroke, which account for 90% of claims. Offered to existing policyholders and their families, it provides multi-stage coverage up to age 85. Policyholders can receive 25% cashback on premiums if no claims are made. This launch addresses a 74% protection gap in critical illness coverage amid rising healthcare costs and demand among residents aged 30 and above."
datetime: "2026-05-21T00:00:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287132135.md)
  - [en](https://longbridge.com/en/news/287132135.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287132135.md)
---

# AIA Singapore targets 90% of illness claims

**The new plan was introduced as part of the insurer’s 95th anniversary.**

AIA Singapore has launched a new critical illness plan, AIA Protect 3, as part of its 95th anniversary, targeting three of the most common serious health conditions in the country.

The plan covers cancer, heart attack and stroke, which together account for about 90% of critical illness claims in Singapore and remain the leading causes of death.

It is being offered exclusively to existing AIA policyholders, including those covered under personal or corporate plans, as well as their spouses and children.

AIA Protect 3 provides multi-stage coverage from early to major stages of illness, with protection extending up to age 85.

Policyholders who do not make a claim can receive 25% cashback on premiums at age 65 or after 15 years, whichever is later.

The launch comes as Singapore faces a reported 74% critical illness protection gap, alongside growing demand for coverage among residents aged 30 and above due to rising healthcare costs and financial uncertainty.

### Related Stocks

- [01299.HK](https://longbridge.com/en/quote/01299.HK.md)
- [AAGIY.US](https://longbridge.com/en/quote/AAGIY.US.md)
- [81299.HK](https://longbridge.com/en/quote/81299.HK.md)

## Related News & Research

- [AIA files HKEX disclosure return, repurchases shares at HKD 84.85-86.3 each](https://longbridge.com/en/news/287195098.md)
- [‘Solve all diseases,’ you say?](https://longbridge.com/en/news/287121830.md)
- [Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade | PPCB Stock News](https://longbridge.com/en/news/287069272.md)
- [<![CDATA[FDA Approves Fasenra for Hypereosinophilic Syndrome]]>](https://longbridge.com/en/news/286576027.md)
- [Medtronic plans to buy SPR Therapeutics for $650 million to expand pain treatment options](https://longbridge.com/en/news/287081570.md)